Keyword: United Kingdom

Midatech Pharma is running out of cash and needs an investor to come on board quickly if it is to rescue its lead drug for cancer and acromegaly.

Government officials floated the idea in a report setting out how the U.K. plans to tackle the threat posed by drug-resistant bacteria.

As Brexit approaches, the U.K. plans to invest £100 million to attract 1,000 Ph.D.s focused on artificial intelligence, including in the life sciences.

U.K. biotech hVIVO is on course to start a phase 3 program for a flu vaccine that doesn’t need to have its composition tweaked every year.

A Cell and Gene Therapy Catapult study shows continued strong growth of advanced therapy medicinal products in the U.K.

Nearly a year after its former chief Eliot Forster stepped down, Immunocore has a new full-time CEO in Medimmune’s president Bahija Jallal.

More than 900 days have passed since the U.K. voted to leave the EU, but the outlook today is more uncertain than on any of the preceding 900 days.

Near-term plans include the creation of a system for assessing study feasibility and an app to connect patients to studies.

The British government unveiled UCB’s investment in its second life science sector deal, which disclosed total spending of £1.3 billion.

The U.K. has been punching below its weight in attracting clinical research, and Brexit could provide an opportunity to remedy that, says ACRO.